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INTRODUCTION 
Japan has several unique points in criteria, screening and edu-
cation systems for metabolic syndrome. In this review, we discuss 
topics related to metabolic syndrome in Japan, including the Japa-
nese criteria for metabolic syndrome; the universal health screen-
ing and education system for metabolic syndrome; and recent de-
bates about Japanese criteria for metabolic syndrome. 
JAPANESE CRITERIA FOR METABOLIC  
SYNDROME
Many definitions of metabolic syndrome have been used world-
wide, but they can be classified into two major types of criteria. 
The definition of the International Diabetes Federation (IDF) rep-
resents one type of criteria [1], while the definitions of the Ameri-
can Heart Association (AHA) and the National Heart, Lung and 
Blood Institute (NHLBI) of the US represent the other type (Fig-
ure 1) [2]. The major difference between these definitions is that 
the IDF criteria regard central obesity as an essential component 
of metabolic syndrome, whereas the AHA criteria focus on the ac-
cumulation of metabolic risk factors. The AHA criteria take waist 
circumference (WC) into consideration as one of five risk factors 
and define metabolic syndrome as the presence of any three com-
ponents out of these five. The Japanese criteria [3] were estab-
Two major definitions of metabolic syndrome have been proposed. One focuses on the accumulation of risk factors, a measure 
used by the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI); the other focuses 
on abdominal obesity, a measure used by the International Diabetes Federation (IDF) and the Japanese government. The latter 
definition takes waist circumference (WC) into consideration as an obligatory component, whereas the former does not. In 2009, 
the IDF, NHLBI, AHA, and other organizations attempted to unify these criteria; as a result, WC is no longer an obligatory com-
ponent of those systems, while it remains obligatory in the Japanese criteria. In 2008, a new Japanese cardiovascular screening 
and education system focused on metabolic syndrome was launched. People undergoing screening are classified into three groups 
according to the presence of abdominal obesity and the number of metabolic risk factors, and receive health educational support 
from insurers. This system has yielded several beneficial outcomes: the visibility of metabolic syndrome at the population level 
has drastically improved; preventive measures have been directed toward metabolic syndrome, which is expected to become 
more prevalent in future generations; and a post-screening education system has been established. However, several problems 
with the current system have been identified and are under debate. In this review, we discuss topics related to metabolic syn-
drome, including (1) the Japanese criteria for metabolic syndrome; (2) metabolic syndrome and the universal health screening 
and education system; and (3) recent debates about Japanese criteria for metabolic syndrome.  
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and control of diabetes mellitus and the prevention of coronary 
heart disease and chronic kidney disease. In 2008, the Japanese 
government launched a new cardiovascular screening and educa-
tion system, focusing on the detection and control of metabolic 
syndrome. 
This policy change was informed by the existence of two major 
types of arteriosclerosis: atherosclerosis, which affects large arter-
ies such as the coronary artery and middle cerebral arteries; and 
arteriolosclerosis, which affects small vessels such as the perforat-
ing arteries in the brain [6]. Atherosclerosis predominates in Amer-
icans and Europeans, reflecting the greater prevalence of dyslipi-
demia, glucose abnormalities, and metabolic syndrome, whereas 
arteriolosclerosis predominates in East Asians, reflecting the great-
er prevalence of hypertension [6]. 
The prevalence of hypertension and arteriolosclerosis has decre-
ased over the past 50 years in Japan, and lifestyle patterns in East 
Asia are undergoing rapid westernization, especially in the mid-
dle-aged urban male population. This is the rationale that the Jap-
anese government considered for changing the target of preven-
tive screening to metabolic syndrome. In addition, although Japan 
has already established a universal health screening system, a post-
screening education system has not been sufficiently developed. 
WC can function as a visible marker for motivating people to make 
lifestyle changes after screening, which is another rationale for the 
government to target metabolic syndrome.
The current system of post-screening measures for metabolic 
syndrome is shown in Figure 2. Based on the results of the screen-
ing, participants are classified into three groups based on the cri-
teria for metabolic syndrome. As previously stated, WC is an es-
sential component of the criteria for metabolic syndrome, and if 
participants exhibit two or more other risk factors, the insurer pro-
vides them with active support for making changes to their life-
style. If they have abdominal obesity and one risk factor, then they 
are assigned to a motivational support group. All other participants 
receive information on preventing metabolic syndrome.
On the one hand, this system has produced several beneficial 
outcomes: the visibility of metabolic syndrome at the population 
level has drastically improved (although many people still confuse 
metabolic syndrome with simple obesity); preventive measures 
have been directed toward metabolic syndrome, which is expect-
ed to become more prevalent in future generations; and a post-screen-
ing education system has been established. On the other hand, sev-
eral problems with this system have been identified, which are now 
under debate.
RECENT DEBATES ON PROBLEMS WITH THE 
JAPANESE UNIVERSAL HEALTH SCREENING 
AND EDUCATION SYSTEM FOR METABOLIC 
SYNDROME 
Debate has arisen concerning the preventive system targeting 
metabolic syndrome and revisions to the program are currently 
under consideration. The following questions have informed the 
lished in 2005 and are quite similar to those of the IDF, except for 
the cutpoint for WC (Figure 1). 
In 2009, the IDF, NHLBI, AHA, and other organizations uni-
fied their criteria [4], and these newer criteria are essentially simi-
lar to the AHA/NHLBI criteria (Figure 1). As a result, only the Jap-
anese criteria maintain WC as an essential component of the defi-
nition.
The prevalence of metabolic syndrome among the Japanese ac-
cording to different criteria was compared in a community sample 
from the Circulatory Risk in Communities Study (1990-1993, Ky-
owa, Japan; subjects aged 40-69 years old) [5]; 33% were evaluated 
by the AHA/NHLBI criteria; 27% were evaluated by the IDF cri-
teria; and 17% were evaluated by the Japanese criteria.
METABOLIC SYNDROME AND THE UNIVERSAL 
HEALTH SCREENING AND EDUCATION SYSTEM
Before the 1950s, the leading cause of death in Japan was tuber-
culosis, and the main measure at that time was the universal tu-
berculosis screening system. From the 1950s to 1980s, the leading 
cause was stroke; thus, the national prevention strategy focused 
on high blood pressure screening. In 1981, cancer overtook stroke, 
and in 1985 heart disease also overtook stroke, followed by pneu-
monia in 2011. Stroke is now the fourth leading cause of death in 
Japan. Given these changes, the Japanese government has shifted 
the target of screening to metabolic syndrome for the prevention 
Figure 1. Selected criteria of metabolic syndrome. IDF, International 
Diabetes Federation; WC, waist circumference; TG, triglyceride; HDL, 
high-density lipoprotein cholesterol; BP, blood pressure; FPG, fast-
ing plasma glucose; AHA, American Heart Association; NHLBI, Na-
tional Heart Lung and Blood Institute; WHF, World Heart Federation; 
IAS, International Atherosclerosis Society; IASO, International Asso-
ciation for the Study of Obesity; BMI, body mass index; SBP, systolic 
blood pressure; DBP, diastolic blood pressure.
Central obesity: based on race  
   and gender specific WC cutoffs
 
                                  Plus
≥2 of the following
   - Elevated TG
   - Reduced HDL
   - Elevated BP
   - Elevated FPG
IDF criteria (2005)
≥3 of the following
   - Elevated WC
   - Elevated TG
   - Reduced HDL
   - Elevated BP
   - Elevated FPG
Harmonized criteria (2009)
IDF, NHLBI, AHA, WHF, IAS, IASO
Central obesity: WC at umbilical level
      men: ≥85 cm,  women: ≥90 cm
                                   Plus
≥2 of the following
   - Elevated TG and/or reduced HDL
   - Elevated BP
   - Elevated FPG
Japanese criteria (2005)
≥3 of the following
   - Elevated WC
   - Elevated TG
   - Reduced HDL
   - Elevated BP
   - Elevated FPG
AHA/NHLBI criteria (2005)
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discussions of the Japanese government commission on the way 
of universal cardiovascular screening and education system.
Q1:  Is metabolic syndrome really important among 
the Japanese?
This question has arisen because many studies have shown that 
the population attributable risk fraction (PAF) of metabolic syn-
drome is not as high as the PAF of high blood pressure. For ex-
ample, the Japan Public Health Center-based Prospective Study 
reported that the PAF of high blood pressure was 50% for men 
and 53% for women, whereas that of metabolic syndrome (based 
on IDF criteria) was 10% for men and 6% for women [7].
However, an upward trend in obesity among East Asian men 
(but not among women, and not as steep as among non-Asians) 
may increase the impact of metabolic syndrome in the near future, 
especially among younger men. Therefore, it has been decided that 
metabolic syndrome is of importance among the Japanese, as a 
matter of disease management and prevention of cardiovascular 
disease in the future.
Q2:  Is it appropriate to keep waist circumference as 
an essential component of the criteria for 
metabolic syndrome?
This question is based on the fact that many studies have shown 
that the PAF of metabolic syndrome itself is not as high as that 
found in the non-obese, but high-risk population. For example, 
the Ibaraki Prefectural Health Study reported that the PAF of car-
diovascular mortality was 10% for persons with a body mass in-
dex (BMI) of ≥ 25 kg/m2 and two or more metabolic risk factors, 
whereas it was 15% for those with a BMI of < 25 kg/m2 and two 
or more metabolic risk factors [8]. 
In response, the committee has determined that it is necessary 
to provide additional health education for non-obese, but high-
risk people.
Q3:  Are the Japanese waist circumference cutpoints 
appropriate?
The harmonized criteria of metabolic syndrome define central 
obesity with race-specific and gender-specific WC cutoffs [4]. Jap-
anese cutoffs are ≥ 85 cm for men and ≥ 90 cm for women, de-
fined based on cross-sectional studies that showed that these cut-
points were equivalent to 100 cm2 of visceral fat area [3]. These 
cutoffs have sometimes been criticized, because only Japan sets 
higher cutoffs for women than men. However, according to a study 
supported by the Ministry of Health, Labour, and Welfare [9], chang-
ing WC cutoffs from 80 to 90 cm had virtually no effect on the 
impact of metabolic syndrome on cardiovascular disease. Taken 
together with the fact that the incidence of cardiovascular disease 
is much lower in women than in men, the committee concluded 
that the WC cutpoints should be maintained as is.
CONCLUSION
The conclusions of this review are as follows. First, the Japanese 
criteria for metabolic syndrome differ in several respects from the 
international criteria, including the use of WC as an essential com-
ponent, with unique WC cutpoints. Second, though a universal 
metabolic syndrome screening and education system was launched 
in 2008, the epidemiological evidence for the metabolic syndrome 
measures was not sufficient at the start of the system’s implemen-
tation. Third, revision of the metabolic syndrome screening sys-
tem is now under consideration, but it is unlikely to be changed 
Figure 2. Current system of post-screening measures for metabolic syndrome. 1Additional risk factors: hyperglycemia (FBS ≥100 mg/dL or 
HbA1c ≥5.6%); dyslipidemia (TG ≥150 mg/dL or HDL ≤40 mg/dL); hypertension (SBP ≥130 mmHg or DBP ≥ 85 mmHg); Smoking. FBS, fast-
ing blood sugar; HbAlc, glycated hemoglobin; TG, triglyceride; HDL, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, 
diastolic blood pressure.
Figure 2
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drastically. Fourth, considering measures of metabolic syndrome 
in East Asia, we should note that the etiology of arteriosclerosis 
differs between East Asians and Westerners. 
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